+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Carrier Screening Market 2024-2028

  • PDF Icon

    Report

  • 140 Pages
  • August 2024
  • Region: Global
  • TechNavio
  • ID: 5561352
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The carrier screening market is forecasted to grow by USD 2.95 billion during 2023-2028, accelerating at a CAGR of 20.62% during the forecast period. The report on the carrier screening market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of genetic diseases and disorders, increasing prevalence of fetal chromosomal abnormalities, and rising consciousness among the masses regarding the benefits of early detection and diagnosis of diseases.

The carrier screening market is segmented as below:

By Type

  • Expanded carrier screening
  • Targeted disease carrier screening

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the rising trends of next-generation sequencing (NGS) technology in carrier screening as one of the prime reasons driving the carrier screening market growth during the next few years. Also, extensive R&D activities in the field of biotechnology and bioinformatics and significant growth in the medical infrastructure will lead to sizable demand in the market.

The report on the carrier screening market covers the following areas:

  • Carrier screening market sizing
  • Carrier screening market forecast
  • Carrier screening market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading carrier screening market vendors that include Abbott Laboratories, Agilent Technologies Inc., CENTOGENE NV, Danaher Corp., DiaSorin SpA, Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Fulgent Genetics Inc., Gene By Gene Ltd, Illumina Inc., Invitae Corp., Laboratory Corp. of America Holdings, MedGenome Labs Ltd., Myriad Genetics Inc., Natera Inc., OPKO Health Inc., Otogenetics Corporation, Quest Diagnostics Inc., Sema4 OpCo Inc., and Thermo Fisher Scientific Inc. Also, the carrier screening market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
2.2 Market characteristics
  • Market characteristics analysis
2.3 Value chain analysis
  • Value Chain Analysis
3 Market Sizing
3.1 Market definition
  • Offerings of companies included in the market definition
3.2 Market segment analysis
  • Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Carrier Screening Market 2018 - 2022
  • Historic Market Size - Data Table on Global Carrier Screening Market 2018 - 2022 ($ million)
4.2 Type segment analysis 2018 - 2022
  • Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type
6.1 Market segments
  • Chart on Type - Market share 2023-2028 (%)
  • Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
  • Chart on Comparison by Type
  • Data Table on Comparison by Type
6.3 Expanded carrier screening - Market size and forecast 2023-2028
  • Chart on Expanded carrier screening - Market size and forecast 2023-2028 ($ million)
  • Data Table on Expanded carrier screening - Market size and forecast 2023-2028 ($ million)
  • Chart on Expanded carrier screening - Year-over-year growth 2023-2028 (%)
  • Data Table on Expanded carrier screening - Year-over-year growth 2023-2028 (%)
6.4 Targeted disease carrier screening - Market size and forecast 2023-2028
  • Chart on Targeted disease carrier screening - Market size and forecast 2023-2028 ($ million)
  • Data Table on Targeted disease carrier screening - Market size and forecast 2023-2028 ($ million)
  • Chart on Targeted disease carrier screening - Year-over-year growth 2023-2028 (%)
  • Data Table on Targeted disease carrier screening - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Type
  • Market opportunity by Type ($ million)
  • Data Table on Market opportunity by Type ($ million)
7 Customer Landscape
7.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape
8.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
8.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 Japan - Market size and forecast 2023-2028
  • Chart on Japan - Market size and forecast 2023-2028 ($ million)
  • Data Table on Japan - Market size and forecast 2023-2028 ($ million)
  • Chart on Japan - Year-over-year growth 2023-2028 (%)
  • Data Table on Japan - Year-over-year growth 2023-2028 (%)
8.9 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.10 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
8.11 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)
9 Drivers, Challenges, and Opportunity/Restraints
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints
10 Competitive Landscape
10.1 Overview
10.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
  • Overview on factors of disruption
10.4 Industry risks
  • Impact of key risks on business
11 Competitive Analysis
11.1 Companies profiled
  • Companies covered
11.2 Market positioning of companies
  • Matrix on companies position and classification
11.3 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
11.4 Danaher Corp.
  • Danaher Corp. - Overview
  • Danaher Corp. - Business segments
  • Danaher Corp. - Key news
  • Danaher Corp. - Key offerings
  • Danaher Corp. - Segment focus
11.5 Eurofins Scientific SE
  • Eurofins Scientific SE - Overview
  • Eurofins Scientific SE - Business segments
  • Eurofins Scientific SE - Key news
  • Eurofins Scientific SE - Key offerings
  • Eurofins Scientific SE - Segment focus
11.6 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
11.7 Fulgent Genetics Inc.
  • Fulgent Genetics Inc. - Overview
  • Fulgent Genetics Inc. - Product / Service
  • Fulgent Genetics Inc. - Key offerings
11.8 Illumina Inc.
  • Illumina Inc. - Overview
  • Illumina Inc. - Business segments
  • Illumina Inc. - Key news
  • Illumina Inc. - Key offerings
  • Illumina Inc. - Segment focus
11.9 Invitae Corp.
  • Invitae Corp. - Overview
  • Invitae Corp. - Product / Service
  • Invitae Corp. - Key offerings
11.10 OPKO Health Inc.
  • OPKO Health Inc. - Overview
  • OPKO Health Inc. - Business segments
  • OPKO Health Inc. - Key offerings
  • OPKO Health Inc. - Segment focus
11.11 Quest Diagnostics Inc.
  • Quest Diagnostics Inc. - Overview
  • Quest Diagnostics Inc. - Business segments
  • Quest Diagnostics Inc. - Key offerings
  • Quest Diagnostics Inc. - Segment focus
11.12 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
12.3 Currency conversion rates for US$
  • Currency conversion rates for US$
12.4 Research methodology
  • Research methodology
12.5 Data procurement
  • Information sources
12.6 Data validation
  • Data validation
12.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
12.8 Data synthesis
  • Data synthesis
12.9 360 degree market analysis
  • 360 degree market analysis
12.10 List of abbreviations
  • List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Incremental Growth
Exhibits 7: Executive Summary - Data Table on Incremental Growth
Exhibits 8: Executive Summary - Chart on Company Market Positioning
Exhibits 9: Parent Market
Exhibits 10: Data Table on - Parent Market
Exhibits 11: Market characteristics analysis
Exhibits 12: Value Chain Analysis
Exhibits 13: Offerings of companies included in the market definition
Exhibits 14: Market segments
Exhibits 15: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Historic Market Size - Data Table on Global Carrier Screening Market 2018 - 2022 ($ million)
Exhibits 20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Type - Market share 2023-2028 (%)
Exhibits 31: Data Table on Type - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Type
Exhibits 33: Data Table on Comparison by Type
Exhibits 34: Chart on Expanded carrier screening - Market size and forecast 2023-2028 ($ million)
Exhibits 35: Data Table on Expanded carrier screening - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Chart on Expanded carrier screening - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Expanded carrier screening - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Targeted disease carrier screening - Market size and forecast 2023-2028 ($ million)
Exhibits 39: Data Table on Targeted disease carrier screening - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Chart on Targeted disease carrier screening - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Targeted disease carrier screening - Year-over-year growth 2023-2028 (%)
Exhibits 42: Market opportunity by Type ($ million)
Exhibits 43: Data Table on Market opportunity by Type ($ million)
Exhibits 44: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 45: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 46: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 47: Chart on Geographic comparison
Exhibits 48: Data Table on Geographic comparison
Exhibits 49: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 50: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 51: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 52: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 53: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 55: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 56: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 57: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 58: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 60: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 61: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 62: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 63: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 64: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 65: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 66: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 67: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 68: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 69: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 70: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 71: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 72: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 73: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 74: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 75: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 76: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 77: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 85: Market opportunity By Geographical Landscape ($ million)
Exhibits 86: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 87: Impact of drivers and challenges in 2023 and 2028
Exhibits 88: Overview on criticality of inputs and factors of differentiation
Exhibits 89: Overview on factors of disruption
Exhibits 90: Impact of key risks on business
Exhibits 91: Companies covered
Exhibits 92: Matrix on companies position and classification
Exhibits 93: Abbott Laboratories - Overview
Exhibits 94: Abbott Laboratories - Business segments
Exhibits 95: Abbott Laboratories - Key news
Exhibits 96: Abbott Laboratories - Key offerings
Exhibits 97: Abbott Laboratories - Segment focus
Exhibits 98: Danaher Corp. - Overview
Exhibits 99: Danaher Corp. - Business segments
Exhibits 100: Danaher Corp. - Key news
Exhibits 101: Danaher Corp. - Key offerings
Exhibits 102: Danaher Corp. - Segment focus
Exhibits 103: Eurofins Scientific SE - Overview
Exhibits 104: Eurofins Scientific SE - Business segments
Exhibits 105: Eurofins Scientific SE - Key news
Exhibits 106: Eurofins Scientific SE - Key offerings
Exhibits 107: Eurofins Scientific SE - Segment focus
Exhibits 108: F. Hoffmann La Roche Ltd. - Overview
Exhibits 109: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 110: F. Hoffmann La Roche Ltd. - Key news
Exhibits 111: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 112: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 113: Fulgent Genetics Inc. - Overview
Exhibits 114: Fulgent Genetics Inc. - Product / Service
Exhibits 115: Fulgent Genetics Inc. - Key offerings
Exhibits 116: Illumina Inc. - Overview
Exhibits 117: Illumina Inc. - Business segments
Exhibits 118: Illumina Inc. - Key news
Exhibits 119: Illumina Inc. - Key offerings
Exhibits 120: Illumina Inc. - Segment focus
Exhibits 121: Invitae Corp. - Overview
Exhibits 122: Invitae Corp. - Product / Service
Exhibits 123: Invitae Corp. - Key offerings
Exhibits 124: OPKO Health Inc. - Overview
Exhibits 125: OPKO Health Inc. - Business segments
Exhibits 126: OPKO Health Inc. - Key offerings
Exhibits 127: OPKO Health Inc. - Segment focus
Exhibits 128: Quest Diagnostics Inc. - Overview
Exhibits 129: Quest Diagnostics Inc. - Business segments
Exhibits 130: Quest Diagnostics Inc. - Key offerings
Exhibits 131: Quest Diagnostics Inc. - Segment focus
Exhibits 132: Thermo Fisher Scientific Inc. - Overview
Exhibits 133: Thermo Fisher Scientific Inc. - Business segments
Exhibits 134: Thermo Fisher Scientific Inc. - Key news
Exhibits 135: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 136: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 137: Inclusions checklist
Exhibits 138: Exclusions checklist
Exhibits 139: Currency conversion rates for US$
Exhibits 140: Research methodology
Exhibits 141: Information sources
Exhibits 142: Data validation
Exhibits 143: Validation techniques employed for market sizing
Exhibits 144: Data synthesis
Exhibits 145: 360 degree market analysis
Exhibits 146: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the carrier screening market: Abbott Laboratories, Agilent Technologies Inc., CENTOGENE NV, Danaher Corp., DiaSorin SpA, Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Fulgent Genetics Inc., Gene By Gene Ltd, Illumina Inc., Invitae Corp., Laboratory Corp. of America Holdings, MedGenome Labs Ltd., Myriad Genetics Inc., Natera Inc., OPKO Health Inc., Otogenetics Corporation, Quest Diagnostics Inc., Sema4 OpCo Inc., and Thermo Fisher Scientific Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rising trends of next-generation sequencing (NGS) technology in carrier screening."

According to the report, one of the major drivers for this market is the rising prevalence of genetic diseases and disorders.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • CENTOGENE NV
  • Danaher Corp.
  • DiaSorin SpA
  • Eurofins Scientific SE
  • F. Hoffmann La Roche Ltd.
  • Fulgent Genetics Inc.
  • Gene By Gene Ltd
  • Illumina Inc.
  • Invitae Corp.
  • Laboratory Corp. of America Holdings
  • MedGenome Labs Ltd.
  • Myriad Genetics Inc.
  • Natera Inc.
  • OPKO Health Inc.
  • Otogenetics Corporation
  • Quest Diagnostics Inc.
  • Sema4 OpCo Inc.
  • Thermo Fisher Scientific Inc.